CS21192A3 - Complex containing precipitation factor ix - Google Patents

Complex containing precipitation factor ix

Info

Publication number
CS21192A3
CS21192A3 CS92211A CS21192A CS21192A3 CS 21192 A3 CS21192 A3 CS 21192A3 CS 92211 A CS92211 A CS 92211A CS 21192 A CS21192 A CS 21192A CS 21192 A3 CS21192 A3 CS 21192A3
Authority
CS
Czechoslovakia
Prior art keywords
factor
complex containing
containing precipitation
precipitation factor
vitamin
Prior art date
Application number
CS92211A
Other languages
English (en)
Inventor
Yendra Dr Linnau
Maria Dipl Ing Sazgary
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of CS21192A3 publication Critical patent/CS21192A3/cs
Publication of CZ280297B6 publication Critical patent/CZ280297B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Medicinal Preparation (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS92211A 1991-01-25 1992-01-24 Komplex obsahující srážecí faktor IX CZ280297B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0016391A AT402261B (de) 1991-01-25 1991-01-25 Komplex enthaltend den gerinnungsfaktor ix

Publications (2)

Publication Number Publication Date
CS21192A3 true CS21192A3 (en) 1992-08-12
CZ280297B6 CZ280297B6 (cs) 1995-12-13

Family

ID=3483232

Country Status (12)

Country Link
US (2) US5281661A (cs)
EP (1) EP0496725B1 (cs)
JP (2) JP2651307B2 (cs)
AT (2) AT402261B (cs)
CA (1) CA2059979C (cs)
CZ (2) CZ280297B6 (cs)
DE (1) DE59207638D1 (cs)
DK (1) DK0496725T3 (cs)
ES (1) ES2098485T3 (cs)
FI (1) FI100111B (cs)
HU (1) HU212362B (cs)
SK (2) SK280130B6 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105282C (en) 1991-03-01 2002-09-24 Centeon L.L.C. Preparation of factor ix
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
US5888826A (en) * 1994-06-30 1999-03-30 Dade Behring Inc. Combination reagent holding and test device
US5602037A (en) * 1994-06-30 1997-02-11 Dade International, Inc. Combination reagent holding and test device
EP0716744B1 (en) 1994-06-30 2001-11-07 Dade Behring Inc. Bioactive porous partition members
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US5958716A (en) * 1996-06-06 1999-09-28 Dade Behring Inc. Blood factor assay
EP1029546A1 (en) * 1997-11-05 2000-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Heparin cofactor ii preparations and process for producing the same
WO2005033140A1 (ja) * 2003-09-30 2005-04-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 高純度血液凝固ｉｘ因子調製物およびその精製方法
WO2006005058A2 (en) * 2004-06-30 2006-01-12 Nektar Therapeutics Al, Corporation Polymer-factor ix moiety conjugates
CN101098883B (zh) * 2004-12-23 2013-01-23 诺和诺德医疗保健公司 减少含有目的维生素k依赖性蛋白质的组合物中的蛋白质污染物的含量
BRPI1012082B1 (pt) 2009-05-27 2022-08-16 Takeda Pharmaceutical Company Limited Método para preparar uma composição de igg concentrada a partir de plasma
HRP20160530T1 (hr) 2009-09-17 2016-07-29 Baxalta Incorporated Stabilna ko-formulacija hijaluronidaze i imunoglobulina, te postupci njezine uporabe
US8795658B2 (en) 2010-09-17 2014-08-05 Baxter International Inc. Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
EP2712423A4 (en) 2011-02-25 2015-06-10 Wellstat Diagnostics Llc Assays for detecting enzymatic activity
WO2025068923A2 (en) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
ATE130620T1 (de) * 1986-01-06 1995-12-15 Blood Systems Inc Therapeutisches blutprodukt, mittel und verfahren zu dessen erzeugung.
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
DE3914869C1 (cs) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
HUT63863A (en) 1993-10-28
CZ154794A3 (en) 1996-04-17
ES2098485T3 (es) 1997-05-01
SK280989B6 (sk) 2000-10-09
US5409990A (en) 1995-04-25
HU212362B (en) 1996-06-28
FI920342A0 (fi) 1992-01-24
EP0496725A3 (en) 1993-05-05
AT402261B (de) 1997-03-25
HU9200225D0 (en) 1992-04-28
CZ280297B6 (cs) 1995-12-13
JP2651307B2 (ja) 1997-09-10
ATA16391A (de) 1996-08-15
CZ280725B6 (cs) 1996-04-17
JPH08259449A (ja) 1996-10-08
JP2866047B2 (ja) 1999-03-08
ATE146220T1 (de) 1996-12-15
US5281661A (en) 1994-01-25
DK0496725T3 (da) 1997-06-09
JPH04295432A (ja) 1992-10-20
FI920342L (fi) 1992-07-26
SK280130B6 (sk) 1999-08-06
CA2059979A1 (en) 1992-07-26
DE59207638D1 (de) 1997-01-23
FI100111B (fi) 1997-09-30
EP0496725B1 (de) 1996-12-11
CA2059979C (en) 2003-04-15
EP0496725A2 (de) 1992-07-29

Similar Documents

Publication Publication Date Title
CS21192A3 (en) Complex containing precipitation factor ix
NZ332625A (en) Concentrated antibody preparation containing greater than 100 mg/ml of the antibody
EP0727437A3 (en) PEG-protein adducts
SE8206168D0 (sv) Preparations and process for preparation thereof
NL300017I1 (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
IL120009A0 (en) Bacterial production of hydrophobic polypeptides
AU586016B2 (en) Method for the treatment of a gas mixture by adsorpton
FI931274A0 (fi) Menetelmä puhdistettujen glykolipidien valmistamiseksi käyttäen membraanierotusmenetelmää
AU597251B2 (en) Method for selectively increasing the ratio of single major components of teicoplanin A2 complex
PL314801A1 (en) Method of purifying vitamin-k-dependent proteins by using a membrane chromatography process
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
TNSN86154A1 (fr) Procede pour la preparation de cefodizime
EG20136A (en) Process for the preparation of 5-chloro-3-chloro-2-thiophenecarloxylic acid esters
ES8706688A1 (es) Procedimiento selectivo para la preparacion del isosorbido-5-mononitrato
HU913573D0 (en) Complexes containing s(+)alkaneacids and alpha-hydroxy-alkaneacids
AU625831B2 (en) Solubilization of t-pa
JPS5251089A (en) Method of immobilizing glutathione-synthetase and process of producing glutathione with the immobilized synthetase
FR2703262B1 (fr) Mélanges gazeux.
JPS6488366A (en) Iron colloid labeling antibody and preparation thereof and histocytochemical detection
JPS55100321A (en) Production of glycoprotein
JPS5261289A (en) Separation of urokinase
JPS56117791A (en) Purification of kallikrein
HU9200196D0 (en) Process for the production of preparations with medicative effect
MX9709657A (es) Preparacion de un polvo de proteina acilada.
JO1388B1 (en) Production of types of mortar for the manufacture of mixed fertilizers

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20020124